16
Views
18
CrossRef citations to date
0
Altmetric
Original Article

A Phase II Trial of Prednisone, Oral Etoposide, and Novantrone (PEN) as Initial Treatment of Non-Hodgkin's Lymphoma in Elderly Patients

, , , , , , , , , & show all
Pages 145-152 | Received 29 Aug 1994, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Dipti Talaulikar, Jane E. Dahlstrom, Bruce Shadbolt, Michelle McNiven, Amy Broomfield & Michael Pidcock. (2007) Occult bone marrow involvement in patients with diffuse large B‐cell lymphoma: results of a pilot study. Pathology 39:6, pages 580-585.
Read now
Giuseppe Milone, Francesco Di Raimondo, Felicina Li Gioi, Giuseppe A. Palumbo, Giovanna Oriella Manenti, Marzia Pafumi & Rosario Giustolisi. (2002) Alternation of Epirubicin and Mitoxantrone in CHOP-like Regimens Retains Efficacy and Reduces Overall Toxicity in Elderly Patients with High and Intermediate Grade Non-Hodgkin Lymphomas. Leukemia & Lymphoma 43:12, pages 2319-2324.
Read now
Michael Crump, Stephen Couban, Ralph Meyer, Leona Rudinskas, Brent Zanke, Stefan Gluck, Andrew Maksymiuk, Paul Hoskins, Sarah Matthews & Elizabeth Eisenhauer. (2002) Phase II Study of Sequential Topotecan and Etoposide in Patients with Intermediate Grade Non-Hodgkin's Lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study. Leukemia & Lymphoma 43:8, pages 1581-1587.
Read now
G. Cartron, L. Voillat, B. Desablens, C. Le Maignan, N. Milpied, C. Foussard, J. Dugay, A. Maakaroun, A. De Muret & P. Colombat. (2001) Continuous Infusion of Vincristine-Doxorubicin with Bolus of Dexamethasone(VAD) Alternated with CHEP in the Treatment of Patients over 60 Years Old with Aggressive Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 40:5-6, pages 529-540.
Read now
F. P. J. Peters, M. A. Ten Haaft & H. C. Schouten. (1999) Intermediate and High Grade Non Hodgkin's Lymphoma in the Elderly. Leukemia & Lymphoma 33:3-4, pages 243-252.
Read now

Articles from other publishers (13)

Haige Ye, Aakash Desai, Dongfeng Zeng, Jorge Romaguera & Michael L. Wang. (2018) Frontline Treatment for Older Patients with Mantle Cell Lymphoma. The Oncologist 23:11, pages 1337-1348.
Crossref
A. Gutiérrez, F. Mestre, G. Pérez-Manga & J. Rodríguez. (2011) Diffuse large B-cell lymphoma in the older. Critical Reviews in Oncology/Hematology 78:1, pages 59-72.
Crossref
Dipti Talaulikar, Bruce Shadbolt, Jane E Dahlstrom & Anne McDonald. (2009) Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI). Journal of Hematology & Oncology 2:1.
Crossref
Mayumi Mori, Kiyoshi Kitamura, Michihiko Masuda, Tomomitsu Hotta, Tamotsu Miyazaki, Akira B. Miura, Hideaki Mizoguchi, Akira Shibata, Hidehiko Saito, Tamotsu Matsuda, Toru Masaoka, Mine Harada, Yoshiyuki Niho & Fumimaro Takaku. (2005) Long-term Results of a Multicenter Randomized, Comparative Trial of Modified CHOP versus THP-COP versus THP-COPE Regimens in Elderly Patients with Non-Hodgkin's Lymphoma. International Journal of Hematology 81:3, pages 246-254.
Crossref
Anas Younes. (2004) New treatment strategies for aggressive lymphoma. Seminars in Oncology 31, pages 10-13.
Crossref
J.K. DoorduijnB. van der HoltG.W. van ImhoffK.G. van der HemM.H.H. KramerM.H.J. van OersG.J. OssenkoppeleM.R. SchaafsmaL.F. VerdonckG.E.G. VerhoefM.M.C. SteijaertI. BuijtC.A. Uyl-de GrootM. van AgthovenA.H. MulderP. Sonneveld. (2003) CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma. Journal of Clinical Oncology 21:16, pages 3041-3050.
Crossref
Luigi Rigacci, Andrea Carpaneto, Renato Alterini, Valentina Carrai, Franco Bernardi, Giampiero Bellesi, Giovanni Longo, Alberto Bosi & Pierluigi Rossi Ferrini. (2002) Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen. Cancer 97:1, pages 97-104.
Crossref
Stuart M. Lichtman, Jonathan Kolitz, Daniel R. Budman, Philip Schulman, Vincent Vinciguerra, Mark Hoffman, Abraham Mittelman, Steven L. Allen, Debra Fusco & Ann F. Hayes. (2001) Treatment of Aggressive Non-Hodgkinʼs Lymphoma in Elderly Patients With Thiotepa, Novantrone (Mitoxantrone), Vincristine, Prednisone (TNOP). American Journal of Clinical Oncology 24:4, pages 360-362.
Crossref
Paul N. MainwaringDavid CunninghamWalter GregoryPeter HoskinBarry HancockAndrew J. NortonKen MacLennanPaul SmithGillian Vaughan HudsonDavid Linch. (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood 97:10, pages 2991-2997.
Crossref
Joseph O. Jacobson, Michael Grossbard, Lawrence N. Shulman & Donna Neuberg. (2000) CHOP Chemotherapy with Preemptive Granulocyte Colony-Stimulating Factor in Elderly Patients with Aggressive Non-Hodgkin's Lymphoma: A Dose-Intensity Analysis. Clinical Lymphoma 1:3, pages 211-217.
Crossref
Stuart M Lichtman. (2000) Aggressive lymphoma in the elderly. Critical Reviews in Oncology/Hematology 33:2, pages 119-128.
Crossref
Umberto Tirelli, Vittorina Zagonel, Domenico Errante, Lucia Fratino & Silvio Monfardini. (1998) Treatment of non-Hodgkin's lymphoma in the elderly: an update. Hematological Oncology 16:1, pages 1-13.
Crossref
D. Quaglino, G. Di Leonardo, N. Furia, F. Recchia, E. Pasqualoni & G. Ciarrocchi. (2013) Therapeutic management of hematological malignancies in elderly patients. Biological and clinical considerations. Aging Clinical and Experimental Research 9:5, pages 310-319.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.